Phospho-MAPK14 (Tyr182) Antibody

Polyclonal Antibody

MAPK14

CSAID Binding Protein 1 antibody, CSAID binding protein antibody, CSAID-binding protein antibody, Csaids binding protein antibody, CSBP 1 antibody, CSBP 2 antibody, CSBP antibody, CSBP1 antibody, CSBP2 antibody, CSPB1 antibody, Cytokine suppressive anti-inflammatory drug-binding protein antibody, EXIP antibody, MAP kinase 14 antibody, MAP kinase MXI2 antibody, MAP kinase p38 alpha antibody, MAPK 14 antibody, MAPK14 antibody, MAX interacting protein 2 antibody, MAX-interacting protein 2 antibody, Mitogen Activated Protein Kinase 14 antibody, Mitogen activated protein kinase p38 alpha antibody, Mitogen-activated protein kinase 14 antibody, Mitogen-activated protein kinase p38 alpha antibody, MK14_HUMAN antibody, Mxi 2 antibody, MXI2 antibody, p38 ALPHA antibody, p38 antibody, p38 MAP kinase antibody, p38 MAPK antibody, p38 mitogen activated protein kinase antibody, p38ALPHA antibody, p38alpha Exip antibody, PRKM14 antibody, PRKM15 antibody, RK antibody, SAPK2A antibody, Stress-activated protein kinase 2a antibody

Peptide sequence around phosphorylation site of tyrosine 182 (T-G-Y(p)-V-A) derived from Human P38 MAPK.

Responds to activation by environmental stress, pro-inflammatory cytokines and lipopolysaccharide (LPS) by phosphorylating a number of transcription factors, such as ELK1 and ATF2 and several downstream kinases, such as MAPKAPK2 and MAPKAPK5. Plays a critical role in the production of some cytokines, for example IL-6. May play a role in stabilization of EPO mRNA during hypoxic stress. Isoform Mxi2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform Exip may play a role in the early onset of apoptosis.

Ming Zheng, et al.(2005) The FASEB Journal. 19: 109-111
Bernt van den et al.(2001) Blink Immunology, 166: 582-587
Arshad Rahman, et al. (2004) Am J Physiol Lung Cell Mol Physiol 287: L1017-L1024
Osamu Yoshino, et al. (2003) Endocrinology &, Metabolism Vol. 88: 2236-2241

Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi

Signal Transduction

Peptide sequence around phosphorylation site of tyrosine 182 (T-G-Y(p)-V-A) derived from Human P38 MAPK.